Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2020 Jan;99(1):e18538.
doi: 10.1097/MD.0000000000018538.

Pain relieving effect of dexmedetomidine in patients undergoing total knee or hip arthroplasty: A meta-analysis

Affiliations
Meta-Analysis

Pain relieving effect of dexmedetomidine in patients undergoing total knee or hip arthroplasty: A meta-analysis

Qi Yang et al. Medicine (Baltimore). 2020 Jan.

Abstract

Background: To evaluate the safety and efficacy of dexmedetomidine in patients undergoing total knee and hip arthroplasty for postoperative pain control.

Methods: An updated systematic review and meta-analysis of randomized controlled trials (RCTs) identified in systematic searches of MEDLINE, EMBASE, Google Scholar, the Cochrane Database and the Chinese SinoMed Database.

Results: Fourteen RCTs with a total of 1220 patients were included. Overall, dexmedetomidine therapy was associated with significantly decreased pain scores 24 hours after surgery (WMD, -0.36; 95% CI, -0.49 to -0.22; I = 90.0%, P < .001) compared with scores in the control group after total hip arthroplasty (THA) and total knee arthroplasty (TKA). Furthermore, the rate of postoperative delirium was also markedly decreased with dexmedetomidine therapy (RR, 0.38; 95% CI, 0.24 to 0.59; I = 0.0%, P < .001). Moreover, compared with the control group, dexmedetomidine treatment was associated with a decreased risk of postoperative nausea and vomiting in patients undergoing TKA (RR, 0.34; 95% CI, 0.15 to 0.79; I = 0.0%, P = .012), and there was a similar risk of hypotension (RR, 1.03; 95% CI, 0.72 to 1.49; I = 24.4%, P = .87) regardless of whether patients underwent TKA or THA. However, the rate of bradycardia was significantly increased with dexmedetomidine treatment in those undergoing TKA (RR, 6.11; 95% CI, 2.35 to 15.91; I = 0.0%, P < .001).

Conclusions: Dexmedetomidine therapy seems to be an effective treatment for pain control and postoperative delirium in patients undergoing TKA/THA. However, the incidence of bradycardia is markedly increased in patients undergoing TKA. Hence, much larger prospective clinical studies are warranted to confirm these findings.

PubMed Disclaimer

Conflict of interest statement

All authors state that there are no conflicts of interest.

Figures

Figure 1
Figure 1
Flow chart.
Figure 2
Figure 2
Risk of bias.
Figure 3
Figure 3
Risk of bias evaluation.
Figure 4
Figure 4
Change of pain intensity evaluated by VAS after dexmedetomidine treatment.
Figure 5
Figure 5
Sensitivity analysis.
Figure 6
Figure 6
Risk of delirium after dexmedetomidine treatment.
Figure 7
Figure 7
Risk of PONV after dexmedetomidine treatment.
Figure 8
Figure 8
Risk of hypotension after dexmedetomidine treatment.
Figure 9
Figure 9
Risk of bradycardia after dexmedetomidine treatment.

References

    1. Grosu I, Lavand’homme P, Thienpont E. Pain after knee arthoplasty: an unresolved issue. Knee Surg Sports Traumatol Arthosc 2014;22:1744–58. - PubMed
    1. Robinson KP, Wagstaff KJ, Sanghera S, et al. Postoperative pain following primary lower limb arthoplasty and enhanced recovery pathway. Ann R Coll Surg Engl 2014;96:302–6. - PMC - PubMed
    1. Aveline C, Roux AL, Hetet HL, et al. Pain and recovery after total knee arthoplasty: a 12-month follow-up after a prospective randomized study evaluating Nefopam and Ketamine for early rehabilitation. Clin J Pain 2014;30:749–54. - PubMed
    1. Lindberg MF, Miaskowski C, RustøEn T, et al. Factors that can predict pain with walking, 12 months after total knee arthoplasty. Acta Orthop 2016;87:600–6. - PMC - PubMed
    1. Correll D. Chonic postoperative pain: recent findings in understanding and management. F1000Res 2017;6:1054. - PMC - PubMed